New antibodies may revolutionize treatment of Epstein-Barr virus

Epstein-Barr virus, linked to cancers and multiple sclerosis among others, now has a new treatment strategy. American researchers have developed antibodies with the potential to revolutionize therapy for EBV infection and its serious complications.